Intrapulmonary Pharmacokinetics of MK-7655, a Novel Beta-lactamase Inhibitor, Dosed in Combination with Imipenem/Cilastatin in Healthy Subjects
Latest Information Update: 23 Sep 2013
At a glance
- Drugs Cilastatin/imipenem/relebactam (Primary)
- Indications Gram-negative infections; Pneumonia
- Focus Pharmacokinetics
- 23 Sep 2013 New trial record
- 12 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.